Novartis Quote - 0K9E

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

76.79

Bid

0.00

Offer

0.00

Volume

200,356

0.00 Day's Range 0.00

76.79 52 Week Range 76.79

Market Cap

156.961B

Previous Close

76.79

Open

Last Trade

104.88

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

5,060

Shares Outstanding

2,044,034,000

Dividend Yield

PE Ratio

14.41

Earnings Per Share (EPS)

7.27

Revenue

54.11B

Net Profit

14.85B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novartis.com

Headquarters

Basel, Che

Founded

Novartis Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0K9E. The last closing price for Novartis was US$76.79. Over the last year, Novartis shares have traded in a share price range of US$ 76.79 to US$ 76.79.

Novartis currently has 2,044,034,000 shares in issue. The market capitalisation of Novartis is US$156.96 billion. Novartis has a price to earnings ratio (PE ratio) of 14.41.

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

N -- Full year net sales for continuing operations1 up 9% (cc2, +6% USD): -- Pharmaceuticals BU growing 12% (cc) driven by Cosentyx USD 3.6 billion (+28% cc), Entresto USD 1.7 billion (+71% cc...

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

N -- Der Nettoumsatz der fortzuführenden Geschäftsbereiche1 steigt 2019 um 9% (kWk2, +6% USD): -- Die Geschäftseinheit Pharmaceuticals wächst um 12% (kWk), getragen von...

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

N -- Hausse du chiffre d'affaires net des activités poursuivies1 de 9% sur l'exercice entier (tcc2, +6% USD): -- Pharmaceuticals: cette unité opérationnelle progresse de...

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

N Basel, January 6, 2020 -- Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned...

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

N -- Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication -- Fevipiprant was well tolerated with adverse events balanced across...

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

N Basel, December 5, 2019 -- Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation...

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

N -- Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve...

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

N -- Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 -- Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to...

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

N -- Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira(R)*[1]...

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

N -- FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study -- Adverse events that might be expected from the...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	76.79	76.79	76.79	4449	76.79	DE
4	76.79	76.79	76.79	11584	76.79	DE
12	76.79	76.79	76.79	5060	76.79	DE
26	76.79	76.79	76.79	3571	76.79	DE
52	76.79	76.79	76.79	9458	76.79	DE
156	76.79	76.79	76.79	21528	76.79	DE
260	76.79	76.79	76.79	17903	76.79	DE

0K9E - Frequently Asked Questions (FAQ)

What is the current Novartis share price?

The current share price of Novartis is US$ 76.79

How many Novartis shares are in issue?

Novartis has 2,044,034,000 shares in issue

What is the market cap of Novartis?

The market capitalisation of Novartis is USD 156.96B

What is the 1 year trading range for Novartis share price?

Novartis has traded in the range of US$ 76.79 to US$ 76.79 during the past year

What is the PE ratio of Novartis?

The price to earnings ratio of Novartis is 14.41

What is the cash to sales ratio of Novartis?

The cash to sales ratio of Novartis is 3.96

What is the reporting currency for Novartis?

Novartis reports financial results in USD

What is the latest annual turnover for Novartis?

The latest annual turnover of Novartis is USD 54.11B

What is the latest annual profit for Novartis?

The latest annual profit of Novartis is USD 14.85B

What is the registered address of Novartis?

The registered address for Novartis is PO BOX, BASEL, 4002

What is the Novartis website address?

The website address for Novartis is www.novartis.com

Which industry sector does Novartis operate in?

Novartis operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CRVCraven House Capital Plc	US$ 0.425 (70.00%)	55.91k
DEMGDeltex Medical Group Plc	0.05p (25.00%)	22.83M
PYXPyx Resources Limited	2.50p (23.46%)	671.42k
EMEEmpyrean Energy Plc	0.15p (20.00%)	565.83M
SALTMicrosalt Plc	82.50p (17.86%)	89.08k
LLAILunglife Ai Inc	1.85p (-81.95%)	5.56M
SDYSpeedy Hire Plc	19.90p (-27.64%)	20.6M
CASSCassell Capital Plc	0.075p (-22.68%)	19.6M
INSPInspirit Energy Holdings Plc	0.0028p (-22.22%)	306.22M
PNNPennon Group Plc	462.20p (-20.03%)	4.73M
MSMNMosman Oil And Gas Limited	0.0425p (6.25%)	1.51B
NTVONativo Resources Plc	0.0018p (0.00%)	786.47M
EMEEmpyrean Energy Plc	0.15p (20.00%)	565.83M
SYMESupply@me Capital Plc	0.0031p (5.08%)	413.64M
TRPTower Resources Plc	0.0295p (0.00%)	322.17M